NAFLD and CKD seem to share important obesity-associated metabolic risk factors, and these two diseases may be driven commonly by obesity-associated mechanisms including lipotoxicity, oxidative stress, enhanced proinflammatory cytokines, and renin-angiotensin-aldosterone system (RAAS) activation [38]. This evidence concerns the gene REN and metabolic dysfunction-associated steatotic liver disease.